Sydney University researchers to get $1.12 million for vaccine testing
Category: #health  By Saipriya Iyer  Date: 2020-11-24
  • sharesocial_share_icon
  • Twitter
  • Facebook
  • LinkedIn

Sydney University researchers to get $1.12 million for vaccine testing

Researchers at the University of Sydney have reportedly been rewarded over $1.12 million as funding from the IMCRC (Innovative Manufacturing CRC) to conduct independent clinical research tests to assess the efficacy of needle-free vaccination for at-risk individuals. The $1.12 million grant reflects the matched funding the university received from the Commonwealth Government funded IMCRC and Australian biotech firm, Vaxxas.

The two new clinical trials are specifically designed to assess the usability, acceptability, feasibility, and safety of Vaxxas’ vaccine delivery technology’s self-administration through an inactive substance. Both studies would aim at healthcare professionals and older adults who are prone to be severely affected by SARS-COV-2 and influenza.

Professor Rachel Skinner, lead researcher, Faculty of Medicine and Health at the University of Sydney, as well as Kids Research at Sydney Children’s Hospital Network, stated that the device offers potential benefits in comparison to vaccination given using a syringe and needle based administration method.

The aim is for the device to need only a small dose of vaccine to create a similar immune response level in the recipient. Additionally, there is no need to refrigerate the device, which makes it easier and cheaper to store and transport. It is also developed to be easy to use, with the ability to be self-administered, added Skinner.

The said device is a biocompatible polymer of one square centimeter, which is smaller than a typical postage stamp, covered in thousands of micro-projections that cannot be seen with a naked eye. These micro-projections are covered with a vaccine formulation and designed to pierce the outer protective layer of the skin to deliver the vaccine to the cell layers that are present immediately below the skin, which is rich in immune cells.

A disposable applicator which contains the product is used to apply the device on the skin. However, this vaccine technology is currently still being developed and has not been authorized for use.

Source credit: https://www.sydney.edu.au/news-opinion/news/2020/11/23/sydney-to-undertake-clinical-studies-of-needle-free-vaccine-patc0.html



About Author

Saipriya Iyer

Email: [email protected]   linkdin twitter

Saipriya Iyer

Saipriya Iyer develops content for Market Size Forecasters, Algosonline, and myriad other platforms. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her bel...

More News By Saipriya Iyer

 Tabletop Tape Dispensers  market valuation to surge at healthy CAGR through 2026

Tabletop Tape Dispensers market valuation to surge at healthy CAGR through 2026

By Saipriya Iyer

A comprehensive research study on Tabletop Tape Dispensers market added by Market Study Report provides insights into the market size and growth trends of this industry over the forecast timeline. The study evaluates key aspects of Tabletop Tape D...

APAC, Europe, America region to generate massive revenues for General Well-Being Dietary Supplements market by 2026

APAC, Europe, America region to generate massive revenues for General Well-Being Dietary Supplements market by 2026

By Saipriya Iyer

MarketStudyReport.com presents latest report on global General Well-Being Dietary Supplements Market, which evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The re...

Eugenia Jambolana Extract Market to Increase Exponentially During 2027

Eugenia Jambolana Extract Market to Increase Exponentially During 2027

By Saipriya Iyer

The report Eugenia Jambolana Extract market provides high-quality information regarding the major market trends, product types and their application scope, competitive landscape, and impact of COVID-19 outbreak.

.

Request a...